Biotech Investors Should Quit the Marketing Games, and Build Real Innovative Companies
Summary
Biotech Investors Should Quit the Marketing Games, and Build Real Innovative Companies Opinion Xconomy San Francisco — I’d like to see people get back to the concept of building companies.The venture capital community over the last seven to eight years has really gone toward binary outcome type of plays.This is opposed to conceptually building sustainable enterprises, based on what the biotech industry was all about to begin with: new science that leads to the ability to create new therapeutics to benefit patients.How do we foster more Dendreons that are successful because they brought something new and innovative to the therapeutic regimen that physicians have to treat patients?It was based on this question we are posing to technology leaders: “What 3 things can San Francisco and Silicon Valley entrepreneurs and VCs do to foster a more stable environment for innovation in IT, life sciences, and energy, and become less wedded to cycles of boom and bust?”]]